LinqMed Inc., a certified venture company of the National Institutes for Quantum Sciences and Technology (QST), is a start-up radiopharmaceutical company to provide innovative “visible” anti-cancer drugs to patients. Formed on July 4th, 2022, our clinical focus is exclusively on cancer, especially, neuro-oncology and pancreatic cancer.